Cite
Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK
MLA
Tariq M. Alhawassi, et al. Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK. Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3cf8cb09a0c9b0a56d684f7fd22c8f8a&authtype=sso&custid=ns315887.
APA
Tariq M. Alhawassi, Kenneth K.C. Man, Frank M.C. Besag, Ruth Brauer, Ian C. K. Wong, & Basmah H. Alfageh. (2020). Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK.
Chicago
Tariq M. Alhawassi, Kenneth K.C. Man, Frank M.C. Besag, Ruth Brauer, Ian C. K. Wong, and Basmah H. Alfageh. 2020. “Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3cf8cb09a0c9b0a56d684f7fd22c8f8a&authtype=sso&custid=ns315887.